© 2000 by Biometrika Trust
Estimating medical costs with censored data
Department of Statistics, North Carolina State University, Raleigh, NC 27695, USA E-mail: hjbang@stat.ncsu.edu; tsiatis@stat.ncsu.edu
Incompleteness of follow-up data is a common problem in estimating medical costs. Native analysis using summary statistics on the collected data can result in severely misleading statistical inference. This paper focuses on the problem of estimating the mean medical cost from a sample of individuals whose medical costs may be right censored. A class of weighted estimators which account appropriately for censoring are introduced. Our estimators are shown to be consistent and asymptotically normal with easily estimated variances. The efficiency of these estimators is studied with the goal of finding as efficient an estimator for the mean medical cost as is feasible. Extensive simulation studies are used to show that our estimators perform well in finite samples, even with heavily censored data, for a variety of circumstances. The methods are applied to a set of cost data from a cardiology trial conducted by the Duke University Medical Center. Extensions to other censored data problems are also discussed.
Key Words: cost analysis; counting process; efficiency; Martingale; missing data; semiparametrics; survival analysis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. M. Kramer, L. H. Curtis, C. S. Dupree, D. Pelter, A. Hernandez, M. Massing, and K. J. Anstrom Comparative Effectiveness of {beta}-Blockers in Elderly Patients With Heart Failure Arch Intern Med, December 8, 2008; 168(22): 2422 - 2428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Anstrom, D. F. Kong, L. K. Shaw, R. M. Califf, J. M. Kramer, E. D. Peterson, S. V. Rao, D. B. Matchar, D. B. Mark, R. A. Harrington, et al. Long-term Clinical Outcomes Following Coronary Stenting Arch Intern Med, August 11, 2008; 168(15): 1647 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Simon, A. Gray, P. Clarke, A. Wade, A. Neil, A. Farmer, and on behalf of the Diabetes Glycaemic Education and Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial BMJ, May 24, 2008; 336(7654): 1177 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Scheike, M.-J. Zhang, and T. A. Gerds Predicting cumulative incidence probability by direct binomial regression Biometrika, March 1, 2008; 95(1): 205 - 220. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Vu, A. Harris, G. Duncan, and G. Sussman Cost-effectiveness of multidisciplinary wound care in nursing homes: a pseudo-randomized pragmatic cluster trial Fam. Pract., August 1, 2007; 24(4): 372 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Eisenstein, K. J. Anstrom, D. F. Kong, L. K. Shaw, R. H. Tuttle, D. B. Mark, J. M. Kramer, R. A. Harrington, D. B. Matchar, D. E. Kandzari, et al. Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation JAMA, January 10, 2007; 297(2): 159 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Luengo-Fernandez, A. M. Gray, and P. M. Rothwell Population-Based Study of Determinants of Initial Secondary Care Costs of Acute Stroke in the United Kingdom Stroke, October 1, 2006; 37(10): 2579 - 2587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Mark, C. L. Nelson, K. J. Anstrom, S. M. Al-Khatib, A. A. Tsiatis, P. A. Cowper, N. E. Clapp-Channing, L. Davidson-Ray, J. E. Poole, G. Johnson, et al. Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure: Results From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Circulation, July 11, 2006; 114(2): 135 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Liao, J. G. Jollis, K. J. Anstrom, D. J. Whellan, D. W. Kitzman, G. P. Aurigemma, D. B. Mark, K. A. Schulman, and J. S. Gottdiener Costs for Heart Failure With Normal vs Reduced Ejection Fraction Arch Intern Med, January 9, 2006; 166(1): 112 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Al-Khatib, K. J. Anstrom, E. L. Eisenstein, E. D. Peterson, J. G. Jollis, D. B. Mark, Y. Li, C. M. O'Connor, L. K. Shaw, and R. M. Califf Clinical and Economic Implications of the Multicenter Automatic Defibrillator Implantation Trial-II Ann Intern Med, April 19, 2005; 142(8): 593 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cook, M. Drummond, and J. F Heyse Economic endpoints in clinical trials Statistical Methods in Medical Research, April 1, 2004; 13(2): 157 - 176. [Abstract] [PDF]
|
|
|
|
|
|
A O'Hagan and J W Stevens Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies Statistical Methods in Medical Research, December 1, 2002; 11(6): 469 - 490. [Abstract] [PDF]
|
|
|
|
|
|
A R Willan, D Y Lin, R J Cook, and E B Chen Using inverse-weighting in cost-effectiveness analysis with censored data Statistical Methods in Medical Research, December 1, 2002; 11(6): 539 - 551. [Abstract] [PDF]
|
|
|
|
|
|
X.-H. Zhou Inferences about population means of health care costs Statistical Methods in Medical Research, August 1, 2002; 11(4): 327 - 339. [Abstract] [PDF]
|
|